Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- Check2 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1; the page remains a 403 error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the usual study record content with an inaccessible error screen. The change includes an added 403 header and HTML, and deletions remove the standard study data and navigation.SummaryDifference21%

- Check23 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new release of the ClinicalTrials.gov page content. This update is likely administrative and does not change the study information presented to users.SummaryDifference0.0%

- Check37 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, signaling a minor update to the page’s metadata. This update does not modify the study details or substantive content shown on the page.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 to reflect a newer version of the page.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the page itself rather than changes to the study information.SummaryDifference0.0%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.